60
ed macular degeneration is associated with increased vascular
endothelial growth factor, hemorheology and endothelial
dysfunction. Ophthalmology 2001; 108 (4): 705-710.
26. Ridker PM. Clinical application of C-reactive protein for
cardiovascular disease detection and prevention. Circulation
2003; 107 (3): 363-369.
27. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen
levels, other cardiovascular risk factors, and age-related mac-
ulopathy: the Blue Mountains Eye Study. Arch Ophthalmol
1998; 116 (5): 583-587.
28. Dasch B, Fuhs A, Behrens T, Meister A, Wellmann J, Fob-
ker M, Pauleikhoff D, Hense HW. Inflammatory markers in
age-related maculopathy: cross-sectional analysis from the
Muenster Aging and Retina Study. Arch Ophthalmol 2005;
123 (11): 1501-6.
29. Age Related Eye Disease Study Research Group, 2005a. A
simplified severity scale for age-related macular degeneration:
AREDS Report nº 18. Arch. Ophthalmol.123(11): 1570 – 4.
30. Tsai DC, Charng MJ, Lee FL, Hsu WM, Chen SJ. Different
plasma levels of vascular endothelial growth factor and nitric
oxide between patients with choroidal and retinal neovascu-
larization. Ophthalmologica 2006; 220 (4): 246-251.
31. Bressler NM, Bressler SB, Seddon JM, Gragoudas ES, Jacob-
son LP. Drusen characteristics in patients with exudative ver-
sus non-exudative age-related macular degeneration. Retina
1998; 8 (2): 109-14.
32. Einbock W, Moessner A, Schnurrbusch UE, Holz FG, Wolf
S. Changes in fundus autofluorescence in patients with age-
related maculopathy. Correlation to visual function: a pro-
spective study. Graefes Arch Clin Exp Ophthalmol 2005;
243 (4): 300-305.
33. Smith RT, Chan JK, Nagasaki T, Sparrow JR, Barbazetto I. A
method of drusen measurement based on reconstruction of fun-
dus background reflectance. Br J Ophthalmol 2005; 89 (1): 87-91.
34. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Hanut-
saha P, Spaide RF, Schwartz SG, Hirschfeld JM, Orlock DA.
Classification of choroidal neovascularization by digital in-
docyanine green videoangiography. Ophthalmology 1996; 103
(12): 2054-2060.
35. Fernandes LH, Freund KB, Yannuzzi LA, Spaide RF, Huang SJ,
Slakter JS, Sorenson JA. The nature of focal areas of hyperfluores-
cence or hot spots imaged with indocyanine green angiography.
Retina 2002; 22 (5): 557-568.
36. Solbach U, Keilhauer C, Knabben H, Wolf S. Imaging of retinal
autofluorescence in patients with age-related macular degenera-
tion. Retina 1997; 17 (5): 385-389.
37. Smith RT, Chan JK, Busuoic M, Sivagnanavel V, Bird AC, Chong
NV. Autofluorescence characteristics of early, atrophic, and high-
risk fellow eyes in age-related macular degeneration. Invest Oph-
thalmol Vis Sci 2006; 47 (12): 5495-5504.
38. Bindewald A, Bird AC, Dandekar SS, Dolar-Szczasny J, Drey-
haupt J, Fitzke FW, Einbock W, Holz FG, Jorzik JJ, Keilhauer C,
Lois N, Mlynski J, Pauleikhoff D, Staurenghi G, Wolf S. Clas-
sification of fundus autofluorescence patterns in early age-related
macular disease. Invest Ophthalmol Vis Sci 2005; 46 (9): 3309-
3314.
39. Spaide RF. Fundus autofluorescence and age-related macular de-
generation. Ophthalmology 2003; 110 (2): 392-399.
40. Stopa M, Bower BA, Davies E, Izatt JA, Toth CA. Correlation
of pathologic features in spectral domain optical coherence tom-
ography with conventional retinal studies. Retina 2008; 28 (2):
298-308.
41. Dolar-Szczasny J, Mackiewicz J, Bindewald A, Holz FG, Zagór-
ski Z. [Fundus autofluorescence examination using a confocal
scanning laser ophthalmoscope HRA (Heidelberg Retina Angi-
ograph)]. Klin Oczna 2005; 107 (7-9): 544-7.
42. Taban M, Williams D, Smith SD, Kaiser PK. Assessing the re-
liability of automated OCT retinal thickness measurements in
patients with choroidal neovascularization due to age-related
macular degeneration. Ophthalmic Surg Lasers Imaging 2010;
41 (2): 166-74.
43. Merin S, Blair NP, Tso MO. Vitreous fluorophotometry in pa-
tients with senile macular degeneration. Invest Ophthalmol Vis
Sci 1987; 28 (4): 756-9.
